Department of Acute Medicine, Oslo University Hospital Ullevaal, Oslo, Norway.
Department of Infectious Diseases, Oslo University Hospital Ullevaal, Oslo, Norway.
Acta Anaesthesiol Scand. 2018 Nov;62(10):1428-1435. doi: 10.1111/aas.13236. Epub 2018 Aug 21.
The aim was to study the course of severe pneumococcal sepsis in patients who rapidly developed septic shock with multiorgan failure.
Combined retrospective and prospective cohort study of all patients with pneumococcal sepsis requiring mechanical ventilation admitted to our Medical Intensive Care Unit at Oslo University Hospital Ullevaal, during an 8-year period (01 January 2006 to 31 December 2013). The inclusion criteria were growth of Streptococcus pneumoniae in blood culture and respiratory failure treated with invasive mechanical ventilation.
Thirty-eight patients were included. Median age was 57 years (interquartile range 49-68, range 22-79). For 84% (32/38), it took <24 hours from the first medical evaluation until they were in septic shock. Initial clinical features were variable; none were treated with antibiotics before hospital admission. Median Sequential Organ Failure Assessment (SOFA) score at admission was 11 (range 1-15) and maximum 15 (range 5-22), all patients developed multiorgan failure. Mutilating complications were seen in 47% (18/38) of the patients: six with amputations, 11 had adverse neurological complications and one patient both. In-hospital mortality was 40% (15/38), 20% (8/38) survived with sequelae and 40% (15/38) returned to their habitual state. Poor outcome was associated with meningitis, disseminated intravascular coagulation, and gastrointestinal symptoms.
In this patient cohort with pneumococcal sepsis and respiratory failure rapid development of septic shock was seen in all cases, even in young healthy individuals. Initial clinical features were variable; none were treated with antibiotics before admission. Mortality was high (40%), as was morbidity with limb amputations and neurological complications.
本研究旨在探讨快速发展为感染性休克并伴有多器官功能衰竭的严重肺炎链球菌败血症患者的病程。
这是一项回顾性和前瞻性队列研究,纳入了在奥斯陆大学医院 Ullevaal 医学重症监护病房接受机械通气治疗的所有肺炎链球菌败血症患者,研究时间为 8 年(2006 年 1 月 1 日至 2013 年 12 月 31 日)。纳入标准为血培养中检出肺炎链球菌和使用有创机械通气治疗的呼吸衰竭。
共纳入 38 例患者。中位年龄为 57 岁(四分位间距 49-68 岁,范围 22-79 岁)。84%(32/38)的患者从首次医疗评估到发生感染性休克的时间<24 小时。初始临床特征各不相同;无 1 例患者在入院前接受过抗生素治疗。入院时的序贯器官衰竭评估(SOFA)评分中位数为 11 分(范围 1-15 分),最高为 15 分(范围 5-22 分),所有患者均发生多器官功能衰竭。47%(18/38)的患者出现破坏性并发症:6 例截肢,11 例发生不良神经并发症,1 例两者均有。院内死亡率为 40%(15/38),20%(8/38)存活且留有后遗症,40%(15/38)恢复到发病前状态。不良预后与脑膜炎、弥漫性血管内凝血和胃肠道症状相关。
本肺炎链球菌败血症和呼吸衰竭患者队列中,所有患者均迅速发展为感染性休克,甚至是年轻健康个体。初始临床特征各不相同;无 1 例患者在入院前接受过抗生素治疗。死亡率高(40%),且发病率高,包括肢体截肢和神经并发症。